Progressive MS Alliance Industry Forum: Maximizing Collective Impact To Enable Drug Development. (October 2016)

• Record Type: Journal Article
• Authors: Zaratin, P.; Comi, G.; Coetzee, T.; Ramsey, K.; Smith, K.; Thompson, A.; Panzara, M.
• Is Part Of: Trends in pharmacological sciences. Volume 37:Number 10(2016)
• Page Start: 808
• Page End: 810
• Publication Date: 2016-10
• Subjects: Pharmacology -- Periodicals; Pharmacology -- trends -- Periodicals; Pharmacologie -- Périodiques; Pharmacology; Electronic journals; Periodicals; 615.1
• DOI: 10.1016/j.tips.2016.07.005
• Languages: English
• ISSNs: 0165-6147

Abstract

Abstract : The Progressive MS Alliance Industry Forum describes a new approach to address barriers to developing treatments for progressive multiple sclerosis (MS). This innovative model promises to facilitate robust collaboration between industry, academia, and patient organizations and accelerate research towards the overarching goal of developing safe and effective treatments for progressive MS.